Product NDC: | 63304-211 |
Proprietary Name: | Glycopyrrolate |
Non Proprietary Name: | Glycopyrrolate |
Active Ingredient(s): | 2 mg/1 & nbsp; Glycopyrrolate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-211 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040844 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090818 |
Package NDC: | 63304-211-69 |
Package Description: | 1 BLISTER PACK in 1 BOX (63304-211-69) > 10 TABLET in 1 BLISTER PACK (63304-211-11) |
NDC Code | 63304-211-69 |
Proprietary Name | Glycopyrrolate |
Package Description | 1 BLISTER PACK in 1 BOX (63304-211-69) > 10 TABLET in 1 BLISTER PACK (63304-211-11) |
Product NDC | 63304-211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Glycopyrrolate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090818 |
Marketing Category Name | ANDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | GLYCOPYRROLATE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |